PBYI
Puma Biotechnology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$9.55
+1.49%Margins
Gross margin
74.8%
EBITDA margin
20.6%
EBIT margin
13.2%
Net margin
11.6%
FCF margin
17.8%
19.3%
Return on equity
13.9%
Return on assets
21.2%
Return on invested capital
1.20x
Asset turnover
$41.1M
Cash from operations
$1.82
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026